Pr Stéphane Oudard
- Specialty
- Oncologist, urology expert
- Title
- Head of service
- Hospital
- Hôpital Européen Georges Pompidou (Paris)
- Latest articles
-
- Belzutifan for von Hippel-Lindau disease-associated renal cell carcinoma and other neoplasms (LITESPARK-004): 50 months follow-up from a single-arm, phase 2 study. (Apr 11, 2025)
- Activity of lenvatinib-based therapy in previously treated patients with metastatic renal cell carcinoma: A European multicenter study (LENVA-LAT). (Mar 26, 2025)
- Soluble TIM-3, likely produced by myeloid cells, predicts resistance to immune checkpoint inhibitors in metastatic clear cell renal cell carcinoma. (Feb 14, 2025)
- Cisplatin- or Carboplatin-Based Chemotherapy Plus Pembrolizumab in Advanced Urothelial Cancer: Exploratory Analysis From the Phase 3 KEYNOTE-361 Study. (Feb 1, 2025)
- Stratification system with dual human endogenous retroviruses for predicting immunotherapy efficacy in metastatic clear-cell renal cell carcinoma. (Jan 22, 2025)